Lupin Strikes Deal For Anti-TB Drug Pretomanid

Company Plans To Commercialize Highly-Drug Resistant TB Medicine In 140 Countries

 
• By Akriti Seth
  
TB tuberculosis lung 3D x-ray
Lupin has entered into a partnership for new Therapy for Highly Drug-Resistant TB • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business